Cyclooxygenase-2 inhibitors for non-small-cell lung cancer: A phase II trial and literature reviewHiroshi Yokouchi(Fukushima Medical University), Masaharu Nishimura(Hokkaido University)Molecular and Clinical OncologyJune 19, 201410.3892/mco.2014.319Cited by 17SaveCiteExport RISWatch citationsRelated Papersγ-Secretase inhibitor enhances antitumour effect of radiation in Notch-expressing lung cancer|British Journal of Cancer|2012|49Familial multifocal micronodular pneumocyte hyperplasia with a novel splicing mutation in TSC1: Three cases in one family|PLoS ONE|2019|8